Alzheimer disease: Absolute quantification of cerebral metabolites in vivo using localized proton magnetic resonance spectroscopy

Alzheimer Disease and Associated Disorders

Volumn 14, Issue 2, 2000, Pages 112-119

  Stoppe, Gabriela ^a   Bruhn, Harald ^b   Pouwels, Petra J W ^b   Hänicke, Wolfgang ^b   Frahm, Jens ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Biomedizinische NMR Forschungs GmbH   (Germany)

Author keywords

Aging; Brain metabolism; Dementia; Magnetic resonance spectroscopy; Spectral quantitation

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN ATROPHY; CELL DENSITY; CELL LOSS; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GLIOSIS; GRAY MATTER; HUMAN; MALE; METABOLITE; NERVE CELL; NEUROPATHOLOGY; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASPARTIC ACID; ATROPHY; BRAIN; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS;

EID: 0343237713     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200004000-00009     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, Revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987.
2. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-16.
3. Besson JAO, Crawford JR, Parker DM, et al. Multimodal imaging in Alzheimer's disease: the relationship between MRI, SPECT, cognitive and pathological changes. Br J Psychiatry 1990;157:216-20.
4. Blacker D, Albert MS, Bassett SS, Go RCP, Harrell LE, Holstein MS. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. Arch Neurol 1994;51:1198-1204.
5. Blass JP. Pathophysiology of the Alzheimer's syndrome. Neurology 1993; 43(Suppl 4):S25-38.
6. Braak H, Braak E. Ratio of pyramidal cells vs. nonpyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Progr Brain Res 1986;70:185-212.
7. Bruhn H, Stoppe G, Merboldt KD, Michaelis T, Hänicke W, Frahm J. Cerebral metabolic alterations in normal aging and Alzheimer's dementia detected by proton MRS. Proceedings of the 11th Annual Meeting of the Society of Magnetic Resonance in Medicine, Berlin Germany, 1992. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1992:752.
8. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995;13:457-62.
9. De Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. Am J Neuroradiol 1993;14:897-906.
10. Eberling JL, Reed BR, Baker MG, Jagust WJ. Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. Arch Neurol 1993;50:761-6.
11. Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type - biochemical and neuropathological correlates. Brain 1988;111:1425-39.
12. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 spectroscopy. Radiology 1997;203:829-36.
13. Flood DG. Thoughts on no neocortical neuronal loss but loss of volume in AD. Neurobiol Aging 1994;15:363-5.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1965;12:189-98.
15. 1H-NMR spectroscopy of human brain: water suppression, short echo times, and 1 mL resolution. J Magn Reson 1990;90:464-73.
16. Frahm J, Gyngell ML, Hänicke W. Rapid scan techniques. In: Stark DD, Bradley WG, eds. Magnetic Resonance Imaging. St. Louis: CV Mosby, 1991;165-203.
17. Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 1996;27:64-9.
18. Fujuyama H, Ogawa M, Yamauchi H, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994; 35:1-6.
19. Jaarsma D, Veenma-van der Duin L, Korf J. N-acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer's disease postmortem brain tissue. J Neurol Sci 1994;127:230-3.
20. Jagust WJ. Functional imaging in dementia: an overview. J Clin Psychiatry 1994;55(Suppl 11):5-11.
21. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76:465-79.
22. Kalaria RN, Harik SI. Reduced glucose transporter at the blood brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 1989;53:1083-8.
23. 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging 1996;17:349-57.
24. Kwo-on-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust WJ. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res 1994;667: 167-74.
25. Lehéricy S, Baulac M, Airas J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer's disease. Am J Neuroradiol 1994;15:927-37.
26. MacKay S, Ezekiel F, Di Sclafani V, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996;198:537-45.
27. Malone MJ, Szoke MC. Neurochemical changes in white matter: Aged human brain and Alzheimer's disease. Arch Neurol 1985;11:1063-6.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D. Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
29. Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch Neurol 1995;52:314-7.
30. Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994; 36:40-7.
31. Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-27.
32. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-7.
33. Moats RA, Ernst T, Shonk TK, Ross BD, Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994;32:110-5.
34. 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Exp Brain Res 1995;102:503-10.
35. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A 1992;89:1671-5.
36. 99mTc-HMPCAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 1996;44:133-8.
37. Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60.
38. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9.
39. Rapoport SI. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. Cerebrovasc Brain Metab Rev 1991;3:297-335.
40. Regeur L, Badsberg Jensen G, Pakkenberg H, Evans SM, Pakkenberg B. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol Aging 1994;15:347-52.
41. Ross BD, Blüml S. New aspects of brain physiology. NMR Biomed 1996;9:279-96.
42. Sandor T, Albert M, Stafford J, Harpley S. Use of computerized CT-analysis to discriminate between Alzheimer patients and normal control subjects. Am J Neuroradiol 1988;9:1181-7.
43. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E∈4 allele distributions in late onset Alzheimer's disease and in other amyloid forming diseases. Lancet 1993;342:710-1.
44. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-72.
45. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72.
46. Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 1995;273:942-7.
47. Snedecor GW, Cochran WG. Statistical methods, 8th ed. Ames, IA: Iowa State University Press, 1989.
48. Stokes CE, Gillon KRW, Hawthorne JN. Free and total lipid myoinositol concentrations decrease with age in human brain. Biochim Biophys Acta 1983;753:136-8.
49. 99mTc HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type: a study under clinical routine conditions. J Neural Transm (Gen Sect) 1995;99: 195-211.
50. Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992;3:12-27.
51. Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HBM. Neuronal atrophy, not cell death is the mam hallmark of Alzheimer's disease. Neurobiol Aging 1994;15:369-71.
52. Tedeschi G, Bertolino A, Lundbom N, et al. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 1996; 47:696-704.
53. Terry RD. Neuropathological changes in Alzheimer disease. Prog Brain Res 1994;101:383-90.
54. Van Gool WA, Walstra GJM, Teunisse S, van der Zant FM, Weinstein HC van Royen EA. Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J Neurol 1995;242:401-5.